Novartis pharmaceuticals A-Z


AFINITOR® (everolimus)

tablets for oral administration

AFINITOR® DISPERZ (everolimus tablets for oral suspension)

Alcaine® (proparacaine hydrochloride ophthalmic solution, USP) 0.5%

Alomide® (lodoxamide tromethamine ophthalmic solution) 0.1%

Argatroban injection

for intravenous infusion only

Arranon® (nelarabine)


Arzerra® (ofatumumab)

injection, for intravenous use

Azopt® (brinzolamide ophthalmic suspension) 1%

Betoptic S® (betaxolol hydrochloride ophthalmic suspension) 0.25%

sterile topical ophthalmic drops

Ciloxan® (ciprofloxacin ophthalmic ointment) 0.3%

Sterile Ophthalmic Ointment

Ciloxan® (ciprofloxacin ophthalmic solution) 0.3%


Ciprodex® (ciprofloxacin and dexamethasone), otic suspension

Cipro® HC OTIC (ciprofloxacin hydrochloride and hydrocortisone otic suspension)

Coartem® (artemether, lumefantrine)


Comtan® (entacapone)


Cosentyx® (secukinumab)

for injection, for subcutaneous use

Cosentyx® (secukinumab)

injection, for subcutaneous use

Cyclogyl® (cyclopentolate hydrochloride ophthalmic solution, USP)

Cyclomydril® (cyclopentolate hydrochloride and phenylephrine hydrochloride ophthalmic solution)

Desferal® (deferoxamine mesylate for injection, USP)


Diovan HCT® (valsartan and hydrochlorothiazide USP)

combination tablets, for oral use

Diovan® (valsartan)

tablets, for oral use

Durezol® (difluprednate ophthalmic emulsion) 0.05%

Emadine® (emedastine difumarate ophthalmic solution) 0.5%

Entresto® (sacubitril and valsartan)

tablets, for oral use

Exelon® (rivastigmine tartrate)

capsules, for oral use

Exelon® Patch (rivastigmine transdermal system)

Exforge HCT® (amlodipine, valsartan, hydrochlorothiozide)

tablets, for oral use

Exforge® (amlodipine and valsartan)

tablets for oral use

Exjade® (deferasirox)

tablets, for oral suspension

Extavia® (interferon beta-1b)

for injection, for subcutaneous use

Farydak® (panobinostat)

capsules, for oral use

Femara® (letrozole)

tablets, for oral use

Flarex® (fluorometholone acetate ophthalmic suspension) 0.1%

Fluorescite® (fluorescein injection, USP) 10%

Focalin® (dexmethylphenidate hydrochloride)


Focalin® XR (dexmethylphenidate hydrochloride)

extended-release capsules CII for oral use

Gilenya® (fingolimod)

capsules, for oral use

Gleevec® (imatinib mesylate)

tablets, for oral use

Hycamtin® (topotecan)

for injection

Hycamtin® (topotecan) capsules

capsules, for oral use

Ilaris® (canakinumab)

for injection, for subcutaneous use

Ilevro® (nepafenac ophthalmic suspension) 0.3%

topical ophthalmic

Iopidine® 0.5% (apraclonidine ophthalmic solution)

0.5% as base

Iopidine® 1% (apraclonidine ophthalmic solution)

1% as base
apraclonidine hydrochloride ophthalmic solution

Isopto® Atropine (atropine sulfate ophthalmic solution) 1%

for topical ophthalmic use

Isopto® Carpine (pilocarpine hydrochloride ophthalmic solution) 1%, 2% and 4%

Jadenu® Sprinkle (deferasirox)

granules, for oral use

Jadenu® (deferasirox)

tablets, for oral use

Kisqali® (ribociclib)

tablets, for oral use

Kisqali® Femara® Co-Pack (ribociclib tablets; letrozole tablets)

co-packaged for oral use

Kymriah™ (tisagenlecleucel)

suspension for intravenous infusion

Lamisil® (terbinafine hydrochloride) oral granules

125 mg and 187.5 mg, for oral use

Lamisil® (terbinafine hydrochloride) tablets

250 mg, for oral use

Lescol® (fluvastatin sodium)


Lescol® XL (fluvastatin sodium)

extended-release tablets for oral use

Lopressor® (metoprolol tartrate injection, USP)

Lotrel® (amlodipine besylate and benazepril hydrochloride)


Maxidex® (dexamethasone ophthalmic suspension) 0.1%

Maxitrol® (neomycin and polymyxin B sulfates and dexamethasone ophthalmic ointment)

Maxitrol® (neomycin and polymyxin B sulfates and dexamethasone ophthalmic suspension)

Mekinist® (trametinib)

tablets, for oral use

Moxeza® (moxifloxacin ophthalmic solution) 0.5%

Mydriacyl® (tropicamide ophthalmic solution, USP)

Myfortic® (mycophenolic acid)

delayed-release tablets, for oral use

Natacyn® (natamycin ophthalmic suspension) 5%

Neoral® (cyclosporine capsules, USP)

soft gelatin capsules

Neoral® (cyclosporine oral solution, USP)

oral solution

Nevanac® (nepafenac ophthalmic suspension) 0.1%

Omnipred® (prednisolone acetate ophthalmic suspension)

Pataday™ (olopatadine hydrochloride ophthalmic solution) 0.2%

Patanase® (olopatadine hydrochloride) Nasal Spray

Patanol® (olopatadine hydrochloride ophthalmic solution) 0.1%

Pazeo® (olopatadine hydrochloride ophthalmic solution) 0.7%

Promacta® (eltrombopag)

tablets, for oral use

Promacta® (eltrombopag)

for oral suspension

Reclast® (zoledronic acid)


Ritalin LA® (methylphenidate hydrochloride)

extended-release capsules

Ritalin SR® (methylphenidate hydrochloride USP)

sustained-release tablets, USP

Ritalin® Hydrochloride (methylphenidate hydrochloride USP)


Rydapt® (midostaurin)

capsules, for oral use

Sandimmune® (cyclosporine capsules, USP)

soft gelatin capsules

Sandimmune® (cyclosporine injection, USP)


Sandimmune® (cyclosporine oral solution, USP)

oral solution

Sandostatin LAR® Depot (octreotide acetate for injectable suspension)

Sandostatin® (octreotide acetate)


Signifor® (pasireotide)

injection, for subcutaneous use

Signifor® LAR (pasireotide)

for injectable suspension, for intramuscular use

Simbrinza® (brinzolamide/brimonidine tartrate ophthalmic suspension) 1%/0.2%

Simulect® (basiliximab)

for injection

Stalevo® (carbidopa, levodopa and entacapone)

tablets, for oral use

Starlix® (nateglinide)

tablets, for oral use

Tafinlar® (dabrafenib)

capsules, for oral use

Tasigna® (nilotinib)

capsules, for oral use

Tegretol® (carbamazepine, USP)

chewable tablets, tablets and suspension

Tegretol® -XR (carbamazepine extended-release tablets)

Tetracaine® (hydrochloride ophthalmic solution) 0.5%

Tobi® (tobramycin inhalation solution, USP)

Tobi® Podhaler™ (tobramycin inhalation powder)

for oral inhalation use

Tobradex® (tobramycin and dexamethasone ophthalmic ointment)

Tobradex® (tobramycin and dexamethasone ophthalmic suspension)

Tobradex® ST (tobramycin/dexamethasone ophthalmic suspension) 0.3%/0.05%

Tobrex® (tobramycin ophthalmic ointment) 0.3%

Tobrex® (tobramycin ophthalmic solution) 0.3%

Travatan Z® (travoprost ophthalmic solution) 0.004%

for topical ophthalmic use

Triesence® (triamcinolone acetonide injectable suspension) 40 mg/mL

Trileptal® (oxcarbazepine)

oral suspension

Trileptal® (oxcarbazepine)

film-coated tablets, for oral use

Tykerb® (lapatinib)

tablets, for oral use

Tyzeka® (telbivudine)

tablets, for oral use

Vigamox® (moxifloxacin ophthalmic solution) 0.5%

Vivelle-Dot® (estradiol transdermal system)

Votrient® (pazopanib)

tablets, for oral use

Xolair® (omalizumab)

for injection, for subcutaneous use

Zofran ODT® (ondansetron)

orally disintegrating tablets

Zofran® (ondansetron hydrochloride)

tablets, for oral use

Zofran® (ondansetron hydrochloride) injection

injection, for intravenous or intramuscular use

Zometa® (zoledronic acid)

injection, for intravenous use

Zortress® (everolimus)

tablets for oral use

Zykadia® (ceritinib)

capsules, for oral use